Turn Therapeutics Inc Sustainability Reports
Turn Therapeutics Inc. operates as a clinical-stage biotechnology company that develops advanced wound care and dermatology solutions. The company leverages its proprietary drug delivery platforms to create targeted, localized treatments for inflammatory and infectious skin conditions, such as eczema and fungal nail infections.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG002QTLH84
1 reports from 2025 to 2025
